NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.
- RT @AtlanticLab: Using mass spectrometry to look at metabolic subtypes for autism spectrum disorder. Recently completed largest metabolomic…2 days ago
- Speaker, author, and autism advocate Temple Grandin urged audiences at Vanderbilt University to embrace neurodivers… https://t.co/iomuQFXV2n2 days ago
- Metabolomics is the study of small molecules, called metabolites, found in our cells, fluids, or tissues; it is the… https://t.co/SN8tBNTrBh2 days ago